Primary biliary cirrhosis screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 17: | Line 17: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Gastroenterology]] | |||
[[Category:Hepatology]] | |||
[[Category:Disease]] | |||
[[Category:Rheumatology]] | |||
[[Category:Medicine]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Primary care]] |
Revision as of 20:08, 7 February 2018
Primary Biliary Cirrhosis Microchapters |
Differentiating Primary Biliary Cirrhosis from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Primary biliary cirrhosis screening On the Web |
American Roentgen Ray Society Images of Primary biliary cirrhosis screening |
Risk calculators and risk factors for Primary biliary cirrhosis screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aysha Anwar, M.B.B.S[2]
Overview
There is insufficient evidence to recommend routine screening for primary biliary cirrhosis. However, patients with PBC having elevated alpha feto protein and male sex, more frequent screening for surveillance of hepatocellular carcinoma is recommended.
Screening
- There is insufficient evidence to recommend routine screening for primary biliary cirrhosis.
- However, patients with primary biliary cirrhosis having elevated alpha feto protein and male sex, more frequent screening for surveillance of hepatocellular carcinoma is recommended. [1][2]
References
- ↑ Jones DE, Metcalf JV, Collier JD, Bassendine MF, James OF (1997). "Hepatocellular carcinoma in primary biliary cirrhosis and its impact on outcomes". Hepatology. 26 (5): 1138–42. doi:10.1002/hep.510260508. PMID 9362353.
- ↑ Silveira MG, Suzuki A, Lindor KD (2008). "Surveillance for hepatocellular carcinoma in patients with primary biliary cirrhosis". Hepatology. 48 (4): 1149–56. doi:10.1002/hep.22458. PMID 18785621.